English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Mancozeb and other 9 active substances extended approval periods in EUqrcode

Mar. 3, 2020

Favorites Print
Forward
Mar. 3, 2020
On December 9, 2019, the European Commission published the Commission Implementing Regulation 2019/2094 of 29 November 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin.

The approval periods of these active substances is extended until January 31, 2021, or February 28, 2021, depending on the substances.
 
This regulation entered into force on December 29, 2019.

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox